Tactile Systems Technology (TCMD) Cash from Investing Activities (2015 - 2026)
Tactile Systems Technology's (TCMD) quarterly Cash from Investing Activities came in at -$7.1 million in Q1 2026, down 1634.89% year-on-year from $460033.1 in Q1 2025, and down 1123.74% on a QoQ basis from -$577000.0 in Q4 2025.
Tactile Systems Technology (TCMD) Cash from Investing Activities (2015 - 2026) Analysis & Trends
Tactile Systems Technology (TCMD) has 12 years of Cash from Investing Activities data on file, last reported at -$7.1 million in Q1 2026.
- On a quarterly basis, Cash from Investing Activities fell 1634.89% year-over-year to -$7.1 million in Q1 2026; TTM through Mar 2026 was -$9.2 million, a 282.56% decrease from a year earlier, with the FY2025 full-year figure at -$2.5 million, down 1.52% from the prior year.
- Cash from Investing Activities for Q1 2026 stood at -$7.1 million, down from -$577000.0 in the prior quarter.
- Over the last five years, Cash from Investing Activities for TCMD reached as high as -$65000.0 in Q4 2022 and fell as low as -$7.1 million in Q1 2026.
- Historically, Cash from Investing Activities has averaged -$969588.2 across 5 years, with a median of -$502000.0 in 2024.
- Across the five-year window, Cash from Investing Activities jumped 98.23% in 2022 and slumped 1634.89% in 2026, its largest moves.
- Year by year, Cash from Investing Activities stood at -$65000.0 in 2022, then sank by 1346.15% to -$940000.0 in 2023, then jumped by 47.66% to -$492000.0 in 2024, then retreated by 17.28% to -$577000.0 in 2025, then plunged by 1123.74% to -$7.1 million in 2026.
- Per Business Quant data, the three most recent Cash from Investing Activities figures were -$7.1 million in Q1 2026, -$577000.0 in Q4 2025, and -$1.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.48 Bn | 176.19 Bn | 6.27 Bn | -20.32 Bn |
| 2 | Stryker | 129.11 Bn | 126.23 Bn | 3.81 Bn | -185.00 Mn |
| 3 | Medtronic | 108.35 Bn | 99.13 Bn | 6.41 Bn | -917.00 Mn |
| 4 | Boston Scientific | 68.68 Bn | 67.22 Bn | 3.61 Bn | -591.00 Mn |
| 5 | Edwards Lifesciences | 48.35 Bn | 44.67 Bn | 1.29 Bn | -92.80 Mn |
| 6 | Dexcom | 28.38 Bn | 27.26 Bn | 750.30 Mn | -298.50 Mn |
| 7 | GE HealthCare Technologies | 28.04 Bn | 25.76 Bn | 1.98 Bn | -2.50 Bn |
| 8 | Smith & Nephew | 26.92 Bn | 26.35 Bn | - | - |
| 9 | Koninklijke Philips | 24.06 Bn | 20.93 Bn | 2.07 Bn | -475.32 Mn |
| 10 | Tactile Systems Technology | 626.75 Mn | 536.56 Mn | 57.61 Mn | -7.06 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -7.06 Mn |
| Mar 31, 2026 | -7.06 Mn |
| Dec 31, 2025 | -577,000.00 |
| Dec 31, 2025 | -577,000.00 |
| Sep 30, 2025 | -1.15 Mn |
| Sep 30, 2025 | -1.15 Mn |
| Jun 30, 2025 | -397,000.00 |
| Jun 30, 2025 | -397,000.00 |
| Mar 31, 2025 | -407,000.00 |
| Mar 31, 2025 | -407,000.00 |
| Dec 31, 2024 | -492,000.00 |
| Dec 31, 2024 | -492,000.00 |
| Sep 30, 2024 | -978,000.00 |
| Sep 30, 2024 | -978,000.00 |
| Jun 30, 2024 | -525,000.00 |
| Jun 30, 2024 | -525,000.00 |
| Mar 31, 2024 | -502,000.00 |
| Mar 31, 2024 | -502,000.00 |
| Dec 31, 2023 | -940,000.00 |
| Dec 31, 2023 | -940,000.00 |